West Pharmaceutical Services (WST) Free Cash Flow (2016 - 2025)
Historic Free Cash Flow for West Pharmaceutical Services (WST) over the last 17 years, with Q3 2025 value amounting to $133.9 million.
- West Pharmaceutical Services' Free Cash Flow rose 3552.63% to $133.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $379.1 million, marking a year-over-year increase of 1787.94%. This contributed to the annual value of $276.4 million for FY2024, which is 3331.72% down from last year.
- Per West Pharmaceutical Services' latest filing, its Free Cash Flow stood at $133.9 million for Q3 2025, which was up 3552.63% from $101.9 million recorded in Q2 2025.
- West Pharmaceutical Services' Free Cash Flow's 5-year high stood at $135.9 million during Q4 2022, with a 5-year trough of $27.6 million in Q1 2024.
- In the last 5 years, West Pharmaceutical Services' Free Cash Flow had a median value of $93.8 million in 2023 and averaged $92.4 million.
- Its Free Cash Flow has fluctuated over the past 5 years, first soared by 15117.65% in 2022, then tumbled by 5071.43% in 2024.
- West Pharmaceutical Services' Free Cash Flow (Quarter) stood at $84.3 million in 2021, then soared by 61.21% to $135.9 million in 2022, then decreased by 4.05% to $130.4 million in 2023, then crashed by 34.66% to $85.2 million in 2024, then soared by 57.16% to $133.9 million in 2025.
- Its Free Cash Flow stands at $133.9 million for Q3 2025, versus $101.9 million for Q2 2025 and $58.1 million for Q1 2025.